Suven Pharmaceuticals Limited has informed the Exchange about change of name of the Company to Cohance Lifesciences Limited

Nclt Scheme FiledListed Co AcquisitionStrategic Transactions View source PDF Explain this filing

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹1102.00

prior close

₹1094.20

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.2%-2.4% vs market

Pharmaceuticals peers, median of 146sector+0.5%-1.7% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Smallcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

+0.4

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2+1.2-2.4+0.5-1.7

Next day

-3.9-0.0-3.9-0.4-3.4

-2.3-0.7-1.6-0.8-1.5

-3.4+3.3-6.7+2.5-5.9

-1.8+4.2-6.0+3.2-5.0

-2.3+5.6-7.9+3.8-6.1

-2.2+8.1-10.2+5.0-7.2

15d

+0.9+10.0-9.1+7.5-6.6

-6.7+15.4-22.1+6.0-12.8

-7.7+16.8-24.5+8.5-16.3

-14.5+10.4-24.9+5.4-19.9

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Suven Pharmaceuticals Limited has officially changed its name to Cohance Lifesciences Limited with effect from May 7, 2025, after receiving approval from the Ministry of Corporate Affairs (MCA). The name change is the final step in the Scheme of Amalgamation under which Cohance Lifesciences Limited (Transferor Company) was merged into Suven Pharmaceuticals Limited (Transferee Company). The scheme was sanctioned by the NCLT Mumbai bench on March 27, 2025. The company will now apply to BSE and NSE to update its name in stock exchange records, while its scrip code (543064) and symbol (SUVENPHAR) remain unchanged for now.

Likely market impact

Shareholders remain unaffected in terms of their holdings; this is purely a rebranding following the completed merger. Investors should expect the stock to trade under the new name 'Cohance Lifesciences' on BSE/NSE once exchanges process the update, and a new scrip symbol may follow later.